Quipt Home Medical Corp. (QIPT)
Mar 16, 2026 - QIPT was delisted
3.650
0.00 (0.00%)
Inactive · Last trade price on Mar 13, 2026
Quipt Home Medical Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Cash & Equivalents | 11.25 | 16.17 | 17.21 | 8.52 | 27.28 | 21.96 |
Cash & Short-Term Investments | 11.25 | 16.17 | 17.21 | 8.52 | 27.28 | 21.96 |
Cash Growth | -21.89% | -6.01% | 102.08% | -68.79% | 24.23% | 126.27% |
Accounts Receivable | 27.01 | 25.12 | 25.56 | 16.38 | 17.83 | 12.06 |
Inventory | 24 | 20.85 | 18.81 | 15.59 | - | - |
Other Current Assets | 6.43 | 6.91 | 3.85 | 1.05 | - | - |
Total Current Assets | 68.69 | 73.05 | 65.43 | 41.54 | 45.11 | 34.03 |
Net Property, Plant & Equipment | 51.85 | 53.86 | 53.41 | 33.5 | 18.53 | 12.52 |
Other Intangible Assets | 63.41 | 67.95 | 74.04 | 28.89 | - | - |
Goodwill | 50.72 | 50.72 | 52.83 | 28.21 | - | - |
Other Long-Term Assets | 1.41 | 1.66 | 1.71 | 0.09 | 21.94 | 7.6 |
Total Assets | 236.09 | 247.25 | 247.41 | 132.21 | 85.58 | 54.15 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Accounts Payable | 36.81 | 35.36 | 32.02 | 13.84 | 25.8 | 18.32 |
Accrued Expenses | - | - | - | 3.45 | - | - |
Current Portion of Long-Term Debt | 13.83 | 16.05 | 17.47 | 8.33 | - | - |
Current Portion of Leases | 5.7 | 5.87 | 5.14 | 3.3 | - | - |
Unearned Revenue | 3.5 | 3.57 | 4.51 | 3.04 | - | - |
Other Current Liabilities | - | - | 1.44 | 5.78 | - | - |
Total Current Liabilities | 59.85 | 60.85 | 60.57 | 37.74 | 25.8 | 18.32 |
Long-Term Debt | 61.66 | 64.57 | 61.35 | 7.73 | - | - |
Long-Term Leases | 11.16 | 13.28 | 14.03 | 7.2 | - | - |
Other Long-Term Liabilities | 0.89 | 1.32 | 0.34 | - | - | - |
Total Long-Term Liabilities | 73.71 | 79.18 | 75.72 | 14.93 | 13.57 | 14.61 |
Total Liabilities | 133.56 | 140.06 | 136.29 | 52.67 | 39.37 | 32.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Common Stock | - | - | - | 214.25 | - | - |
Additional Paid-in Capital | 280.26 | 277.76 | 274.92 | 26.32 | - | - |
Retained Earnings | -177.72 | -170.57 | -163.81 | -161.02 | - | - |
Total Common Shareholders' Equity | 102.54 | 107.19 | 111.12 | 79.55 | - | - |
Shareholders' Equity | 102.54 | 107.19 | 111.12 | 79.55 | 46.21 | 21.22 |
Total Liabilities & Equity | 236.09 | 247.25 | 247.41 | 132.21 | 85.58 | 54.15 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Total Debt | 92.35 | 99.78 | 97.98 | 26.56 | 0 | 0 |
Net Cash (Debt) | -81.1 | -83.6 | -80.77 | -18.05 | 27.28 | 21.96 |
Net Cash Growth | - | - | - | - | 24.23% | - |
Net Cash Per Share | -1.88 | -1.97 | -2.09 | -0.50 | 0.90 | 0.97 |
Book Value | 102.54 | 107.19 | 111.12 | 79.55 | 0 | 0 |
Book Value Per Share | 2.37 | 2.52 | 2.88 | 2.19 | - | - |
Tangible Book Value | -11.59 | -11.48 | -15.75 | 22.45 | 0 | 0 |
Tangible Book Value Per Share | -0.27 | -0.27 | -0.41 | 0.62 | - | - |